Premium
The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus
Author(s) -
Keeling D. M.,
Campbell S. J.,
Mackie I. J.,
Machin S. J.,
Isenberg D. A.
Publication year - 1991
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1991.tb08583.x
Subject(s) - medicine , fibrinolysis , lupus anticoagulant , thrombosis , plasminogen activator , venous thrombosis , immunology , antiphospholipid syndrome , lupus erythematosus , antibody , plasminogen activator inhibitor 1 , gastroenterology , protein c , tissue plasminogen activator
Summary Patients with systemic lupus erythematosus (SLE) have an increased risk of thrombosis and this is increased in the presence of antiphospholipid antibodies (APA). These APA are also associated with thrombosis in patients who do not have SLE. We compared haemostatic parameters in SLE patients with and without APA, and also compared patients who had APA but not SLE with healthy normal controls. No relationships between the natural anticoagulants. anti‐thrombin III, heparin cofactor II, protein C and protein s. and the presence of APA were found. In the patients with SLE both tissue plasminogen activator antigen and plasminogen activator inhibitor (PAI) were increased, but these changes were not due to APA which had no effect on fibrinolysis in these patients. In the patients with APA who did not have SLE the fibrinolytic response to venous occlusion was reduced due to raised levels of PAI; similar changes have, however, been reported in some patients with idiopathic thrombosis.